These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 16761190)

  • 21. Celiprolol, a vasodilatory beta-blocker, inhibits pressure overload-induced cardiac hypertrophy and prevents the transition to heart failure via nitric oxide-dependent mechanisms in mice.
    Liao Y; Asakura M; Takashima S; Ogai A; Asano Y; Shintani Y; Minamino T; Asanuma H; Sanada S; Kim J; Kitamura S; Tomoike H; Hori M; Kitakaze M
    Circulation; 2004 Aug; 110(6):692-9. PubMed ID: 15262839
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chronic inhibition of nitric oxide synthesis causes coronary microvascular remodeling in rats.
    Numaguchi K; Egashira K; Takemoto M; Kadokami T; Shimokawa H; Sueishi K; Takeshita A
    Hypertension; 1995 Dec; 26(6 Pt 1):957-62. PubMed ID: 7490155
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cardiac aldosterone production in genetically hypertensive rats.
    Takeda Y; Yoneda T; Demura M; Miyamori I; Mabuchi H
    Hypertension; 2000 Oct; 36(4):495-500. PubMed ID: 11040225
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of aldosterone and angiotensin II receptor blockade on cardiac angiotensinogen and angiotensin-converting enzyme 2 expression in Dahl salt-sensitive hypertensive rats.
    Takeda Y; Zhu A; Yoneda T; Usukura M; Takata H; Yamagishi M
    Am J Hypertens; 2007 Oct; 20(10):1119-24. PubMed ID: 17903697
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Additive amelioration of left ventricular remodeling and molecular alterations by combined aldosterone and angiotensin receptor blockade after myocardial infarction.
    Fraccarollo D; Galuppo P; Schmidt I; Ertl G; Bauersachs J
    Cardiovasc Res; 2005 Jul; 67(1):97-105. PubMed ID: 15949473
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of local aldosterone by eplerenone reduces renal structural damage in a novel model of chronic cyclosporine A nephrotoxicity.
    Sun QL; Li M; Rui HL; Chen YP
    J Renin Angiotensin Aldosterone Syst; 2015 Jun; 16(2):301-10. PubMed ID: 25500744
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aldosterone receptor antagonism normalizes vascular function in liquorice-induced hypertension.
    Quaschning T; Ruschitzka F; Shaw S; Lüscher TF
    Hypertension; 2001 Feb; 37(2 Pt 2):801-5. PubMed ID: 11230376
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of eplerenone, a selective aldosterone blocker, on the progression of left ventricular dysfunction and remodeling in rats with dilated cardiomyopathy.
    Wahed MI; Watanabe K; Ma M; Yamaguchi K; Takahashi T; Tachikawa H; Kodama M; Aizawa Y
    Pharmacology; 2005 Feb; 73(2):81-8. PubMed ID: 15467302
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cardioprotective mechanisms of eplerenone on cardiac performance and remodeling in failing rat hearts.
    Kobayashi N; Yoshida K; Nakano S; Ohno T; Honda T; Tsubokou Y; Matsuoka H
    Hypertension; 2006 Apr; 47(4):671-9. PubMed ID: 16505212
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Systemic Aldosterone, But Not Angiotensin II, Plays a Pivotal Role in the Pathogenesis of Renal Injury in Chronic Nitric Oxide-Deficient Male Rats.
    Suehiro T; Tsuruya K; Ikeda H; Toyonaga J; Yamada S; Noguchi H; Tokumoto M; Kitazono T
    Endocrinology; 2015 Jul; 156(7):2657-66. PubMed ID: 25872005
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Melatonin prevents fibrosis but not hypertrophy development in the left ventricle of NG-nitro-L-arginine-methyl ester hypertensive rats.
    Paulis L; Pechanova O; Zicha J; Krajcirovicova K; Barta A; Pelouch V; Adamcova M; Simko F
    J Hypertens Suppl; 2009 Aug; 27(6):S11-6. PubMed ID: 19633445
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regulation of angiotensin II receptor expression by nitric oxide in rat adrenal gland.
    Usui M; Ichiki T; Katoh M; Egashira K; Takeshita A
    Hypertension; 1998 Sep; 32(3):527-33. PubMed ID: 9740621
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Opening of ATP-sensitive potassium channel attenuates cardiac remodeling induced by chronic inhibition of nitric oxide synthesis].
    Sanada S; Node K; Asanuma H; Ogita H; Takashima S; Minamino T; Asakura M; Hori M; Kitakaze M
    J Cardiol; 2003 Jan; 41(1):43-4. PubMed ID: 12564115
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Blood pressure variability activates cardiac mineralocorticoid receptor and induces cardiac remodeling in hypertensive rats.
    Yasuoka S; Kai H; Kajimoto H; Kudo H; Takayama N; Anegawa T; Koga M; Miyamoto T; Mifune H; Kage M; Hirooka Y; Imaizumi T
    Circ J; 2013; 77(6):1474-81. PubMed ID: 23470864
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combination therapy with telmisartan and spironolactone alleviates L-NAME exacerbated nephrosclerosis with an increase in PPAR-gamma and decrease in TGF-beta(1).
    Takahashi T; Ono H; Ono Y; Ishimitsu T; Matsuoka H
    Int Heart J; 2007 Sep; 48(5):637-47. PubMed ID: 17998773
    [TBL] [Abstract][Full Text] [Related]  

  • 36. L-NAME-induced protein remodeling and fibrosis in the rat heart.
    Pechánová O; Bernátová I; Pelouch V; Babál P
    Physiol Res; 1999; 48(5):353-62. PubMed ID: 10625224
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Eplerenone enhances cardioprotective effects of standard heart failure therapy through matricellular proteins in hypertensive heart failure.
    Muñoz-Pacheco P; Ortega-Hernández A; Caro-Vadillo A; Casanueva-Eliceiry S; Aragoncillo P; Egido J; Fernández-Cruz A; Gómez-Garre D
    J Hypertens; 2013 Nov; 31(11):2309-18; discussion 2319. PubMed ID: 24077250
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of Mineralocorticoid Receptor Blockade and Statins on Kidney Injury Marker 1 (KIM-1) in Female Rats Receiving L-NAME and Angiotensin II.
    Huang J; Caliskan Guzelce E; Gholami SK; Gawelek KL; Mitchell RN; Pojoga LH; Romero JR; Williams GH; Adler GK
    Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047470
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Participation of aldosterone in the vascular inflammatory response of spontaneously hypertensive rats: role of the NFkappaB/IkappaB system.
    Sanz-Rosa D; Cediel E; de las Heras N; Miana M; Balfagón G; Lahera V; Cachofeiro V
    J Hypertens; 2005 Jun; 23(6):1167-72. PubMed ID: 15894892
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hydrogen sulfide ameliorated L-NAME-induced hypertensive heart disease by the Akt/eNOS/NO pathway.
    Jin S; Teng X; Xiao L; Xue H; Guo Q; Duan X; Chen Y; Wu Y
    Exp Biol Med (Maywood); 2017 Dec; 242(18):1831-1841. PubMed ID: 28971696
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.